A new kind of single-dose vaccine that comes in a nasal spray and doesn’t require refrigeration could dramatically alter the public health landscape — get more people vaccinated around the world and address the looming threats of emerging and re-emerging diseases.
Researchers presented the latest design and testing of these “nanovaccines” at the 247th National Meeting & Exposition of the American Chemical Society (ACS), the world’s largest scientific society.
Their talk was one of more than 10,000 presentations at the meeting, being held here through Thursday at the Dallas Convention Center and area hotels.
“Our nanovaccine approach could be instrumental for containing future outbreaks of recently emerged and re-emerging diseases, such as SARS, new flu strains and multi-drug resistant tuberculosis,” said Balaji Narasimhan, Ph.D., the project’s lead researcher.
He noted that most of today’s vaccines require needles, boosters and refrigeration, all of which pose challenges for doctors and patients. Other than the pain factor, which can lower the chances that someone will seek out a vaccine, follow-up shots and refrigeration further reduce the reach of these vitally important preventive treatments. In some places with limited resources, refrigeration simply isn’t available. Thus, many people who need vaccinations the most aren’t getting them at all. The good news is that the vaccines Narasimhan’s team is developing don’t need to be kept cold and are easy to administer.
“Our nanovaccines can be stored at room temperature for as long as six to 10 months and still work,” said Narasimhan, who’s at Iowa State University. “Also, we’re designing them so they get delivered in one dose through a nasal spray, which could potentially allow patients to give the vaccine to themselves.”
Another major limitation of traditional vaccines is the way they work, he said. Most current vaccines help a person develop disease immunity by introducing part of a virus or bacteria and triggering the body’s humoral response — the part of the immune system that produces antibodies to fight off a harmful pathogen. Later, if the person gets infected by that microbe, the body immediately knows how to respond.
But increasingly, evidence is emerging that the other component of the body’s immune system, what’s called the cell-mediated arm, also plays an important part in some emerging and re-emerging diseases, such as whooping cough. This side of the immune system depends on a group of cells called T cells, rather than antibodies, to fight viruses and bacteria.
Part of the elegance of these nanovaccines is their simplicity and versatility, Narasimhan explained. They are made of only two components: bits of proteins from a virus or bacteria packed into nontoxic, biodegradable polymers that can be custom-designed.
When administered through the nose or by a shot, these tiny packages enter the body and flag the immune system. Sentinels called antigen-presenting cells that keep watch in the body for foreign invaders gobble up the nanovaccine particles, chop up the polymers and pathogen proteins, and appropriately put pieces of the proteins on their surfaces. Depending on the chemistry of the nanovaccine, this triggers the body’s cell-mediated or humoral immune response and trains it to recognize the pathogen and attack it quickly in case of future infections.
“We have exciting results that attest to the ability of the nanovaccine formulations to do a very good job of activating cell-mediated immunity,” said Narasimhan. “We’ve shown that it works with rodents, and we’re moving forward to show that in larger animals, as well.”
The Latest on: Spray vaccine
via Google News
The Latest on: Spray vaccine
- Flu Season Starting to Ramp Up in the Southon November 15, 2019 at 4:10 pm
Plenty of vaccine is available, Brammer said. So far, about 162 million doses have been distributed. For kids and some adults who don't like shots, a nasal spray vaccine is available. It's ...
- Flu vaccine delay for schoolchildren across Scotlandon November 13, 2019 at 4:29 pm
Priority is being given to at-risk and younger children, with P4-7 pupils facing the most disruption. A UK-wide shortage of the nasal spray Fluenz Tetra has meant health boards are receiving fewer ...
- Influenza Vaccine Market to Reach $6.20 Bn, Globally, by 2026 at 5.9% CAGR: Allied Market Researchon November 12, 2019 at 1:44 am
Influenza Vaccine Market by Vaccine Type (Quadrivalent and Trivalent), Type (Seasonal and Pandemic), Technology (Egg-based and Cell-based), Age Group (Pediatric and Adult), and Route of Administration ...
- The flu vaccine is not 100% effective but you should still get it every yearon November 11, 2019 at 12:46 pm
The flu vaccine is usually 40% to 60% effective, but some years it can be as low as 20% effective. It's still your best defense against the flu.
- Flu vaccine delay will put one million schoolchildren at risk – how to protect your kidson November 8, 2019 at 4:45 am
And they warned up to one million kids could be left unprotected - after a quarter of the vaccines were held back by testing problems. As a result Public Health England has told schools to cancel ...
- Flu jab shortage: Child flu vaccine delayed - what to do if your child is at riskon November 8, 2019 at 12:21 am
A quarter of nasal spray vaccines ordered for children ahead of the flu season have been delayed, Public Health England (PHE) has announced. AstraZeneca said around a quarter of its batches due to ...
- GPs told to prioritise toddlers amid flu vaccine shortageson November 7, 2019 at 10:40 am
For the first time, all children aged between two and 11 were due to be eligible for a free nasal spray inoculation, with most receiving them at school. But manufacturers have been beset by problems ...
- Flu-vaccine nasal spray delayed for some schoolchildrenon November 7, 2019 at 8:30 am
There will be a delay in some batches of nasal-spray flu vaccine being delivered to schools in England, it has been announced. Public Health England said some schools would need to reschedule plans ...
- Quarter of nasal spray flu vaccines for children delayedon November 7, 2019 at 8:26 am
A quarter of the nasal spray vaccines ordered for children ahead of the flu season have been delayed, Public Health England (PHE) said. AstraZeneca said around a quarter of its batches due to arrive ...
- Could there be a way to prevent stress with a 'vaccine'?on November 6, 2019 at 3:11 am
That means a vaccine, a pill, a nasal spray, could actually stop stress -- and everything that comes with it -- before you feel stressed out! The vaccine could also possibly help prevent other ...
via Bing News